Zidovudine (ZDV)
Sponsors
Institut de Recherche pour le Developpement, French National Agency for Research on AIDS and Viral Hepatitis, National Institute of Allergy and Infectious Diseases (NIAID), Boehringer Ingelheim
Conditions
HIV Infections
Phase 2
One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine
CompletedNCT00142337
Start: 2004-12-31End: 2009-02-28Updated: 2012-01-06
Tipranavir Dose-response Study Using a Prototype Self-emulsifying Drug Delivery System (SEDDS) Formulation in Treatment-naive HIV-1 Infected Patients Report on the Post-study Option, a Treatment of Triple Therapy With Delavirdine, ZDV and 3TC Without Tipranavir
CompletedNCT02249130
Start: 1999-03-31Updated: 2014-09-25
Phase 3
Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN)
CompletedNCT00158405
Start: 2002-12-31End: 2006-12-31Updated: 2008-12-30
Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries
CompletedNCT01061151
Start: 2011-03-01End: 2016-09-30Updated: 2022-02-11
Efficacy of Nevirapine Compared to ZDV + 3TC Administered in Labor and Again at Postdelivery in HIV Positive Women
CompletedNCT02181933
Start: 1999-04-30Updated: 2014-07-14